Stockscreener 앱 받기
7.07
1.00%
0.07
시간 외 거래:
7.07
전일 마감가:
$7.00
열려 있는:
$6.98
하루 거래량:
424.37K
Relative Volume:
0.65
시가총액:
$382.43M
수익:
$2.81M
순이익/손실:
$-97.34M
주가수익비율:
-4.4747
EPS:
-1.58
순현금흐름:
$-91.47M
1주 성능:
-2.75%
1개월 성능:
+3.67%
6개월 성능:
+126.60%
1년 성능:
+122.33%
1일 변동 폭
$6.6901
$7.13
1주일 범위
$6.6901
$7.41
52주 변동 폭
$2.315
$8.50
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
명칭
Fulcrum Therapeutics Inc
전화
617-651-8851
주소
26 LANDSDOWNE STREET, CAMBRIDGE, MA
FULC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
7.07 | 378.64M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-09-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-09-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-05-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2023-09-25 | 개시 | Goldman | Neutral |
| 2023-08-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | 업그레이드 | Stifel | Hold → Buy |
| 2023-05-04 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-03-10 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-02-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-11-15 | 개시 | Goldman | Buy |
| 2022-03-08 | 개시 | Oppenheimer | Outperform |
| 2022-03-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-08-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-03-22 | 개시 | Credit Suisse | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2020-10-16 | 개시 | Piper Sandler | Overweight |
| 2020-08-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-08-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2019-10-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-12 | 개시 | BofA/Merrill | Buy |
모두보기
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
Market Catalysts: Is Fulcrum Therapeutics Inc benefiting from innovation trendsJuly 2025 Patterns & Expert Approved Momentum Ideas - خودرو بانک
Technical analysis overview for Fulcrum Therapeutics Inc. stockTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Applying chart zones and confluence areas to Fulcrum Therapeutics Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
Fulcrum Therapeutics, Inc. $FULC Shares Bought by Exome Asset Management LLC - MarketBeat
Published on: 2025-09-15 03:06:05 - newser.com
147,654 Shares in Fulcrum Therapeutics, Inc. $FULC Acquired by Jacobs Levy Equity Management Inc. - MarketBeat
Using flow based indicators on Fulcrum Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Volume spikes in Fulcrum Therapeutics Inc. stock – what they meanPortfolio Return Report & Technical Entry and Exit Tips - newser.com
Institutional scanner results for Fulcrum Therapeutics Inc.Market Growth Summary & Stepwise Trade Execution Plans - Newser
Is Fulcrum Therapeutics Inc. reversing from oversold territoryJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Invesco Ltd. Acquires 55,791 Shares of Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Short interest data insights for Fulcrum Therapeutics Inc.Insider Buying & Technical Confirmation Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Top chart patterns to watch in Fulcrum Therapeutics Inc.Market Movers & Low Drawdown Momentum Trade Ideas - Newser
Will a bounce in Fulcrum Therapeutics Inc. offer an exitTrade Exit Summary & Risk Controlled Stock Alerts - Newser
What’s next for Fulcrum Therapeutics Inc. stock priceJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Real time breakdown of Fulcrum Therapeutics Inc. stock performanceTrade Signal Summary & Entry Point Strategy Guides - Newser
Fulcrum Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
How to use Fibonacci retracement on Fulcrum Therapeutics Inc.July 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
35,000 Stock Options at $7.27: Fulcrum Therapeutics Awards New Employee Compensation Package - Stock Titan
Custom watchlist performance reports with Fulcrum Therapeutics Inc.2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing recovery setups for Fulcrum Therapeutics Inc. investorsStop Loss & Daily Stock Trend Reports - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
What institutional flow reveals about Fulcrum Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Is this a good reentry point in Fulcrum Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Is Fulcrum Therapeutics Inc. stock entering bullish territoryJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Fulcrum Therapeutics Inc. stock prediction for this weekIndex Update & Safe Entry Zone Tips - Newser
Market reaction to Fulcrum Therapeutics Inc.’s recent newsJuly 2025 Technicals & Technical Pattern Alert System - Newser
Combining machine learning predictions for Fulcrum Therapeutics Inc.Market Volume Report & Daily Entry Point Trade Alerts - Newser
Strategies to average down on Fulcrum Therapeutics Inc.July 2025 Technicals & Verified Entry Point Signals - Newser
How sentiment analysis helps forecast Fulcrum Therapeutics Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock daily chart insightsJuly 2025 Setups & Weekly High Return Forecasts - Newser
Using Bollinger Bands to evaluate Fulcrum Therapeutics Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Has Fulcrum Therapeutics Inc. formed a bullish divergence2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Is Fulcrum Therapeutics Inc. stock reversal real or fakeJuly 2025 Rallies & AI Powered Market Entry Strategies - Newser
Advanced analytics toolkit walkthrough for Fulcrum Therapeutics Inc.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - Newser
Will Fulcrum Therapeutics Inc. rebound enough to break evenRisk Management & Free High Accuracy Swing Entry Alerts - Newser
Fulcrum Therapeutics Inc (FULC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.33%
0.05%
자본화:
|
볼륨(24시간):